Dr. Todd Morgan

And the answer is no, as far as we can tell. Now, you know, we can talk about, you know, maybe carve-outs for patients at really high risk of recurrence who maybe were undersampled in these studies. But really, you know, waiting until biochemical recurrence is totally appropriate, saves a ton of patients from unnecessary salvage treatment. And so that's where the field has moved, right?

Yeah, stylistically, I think it comes up a lot pre-op. It should come up a lot during that initial consultation, but certainly not every time. I think we talk about risk of recurrence, right? So we get to go through the whole discussion, surgery versus radiation for the patient who's thinking about surgery. We talk about all the usual quality of life risks, surgical expectations.

Yeah, stylistically, I think it comes up a lot pre-op. It should come up a lot during that initial consultation, but certainly not every time. I think we talk about risk of recurrence, right? So we get to go through the whole discussion, surgery versus radiation for the patient who's thinking about surgery. We talk about all the usual quality of life risks, surgical expectations.

Yeah, stylistically, I think it comes up a lot pre-op. It should come up a lot during that initial consultation, but certainly not every time. I think we talk about risk of recurrence, right? So we get to go through the whole discussion, surgery versus radiation for the patient who's thinking about surgery. We talk about all the usual quality of life risks, surgical expectations.

And then we do really try to address what I think is a common misunderstanding that Once the prostate is out, the patient is guaranteed to never recur. And patients, I think, are often surprised. What do you mean? I thought if the prostate's gone, how can I get it again? And why are you checking my PSA? Or why would you check my PSA after surgery?

And then we do really try to address what I think is a common misunderstanding that Once the prostate is out, the patient is guaranteed to never recur. And patients, I think, are often surprised. What do you mean? I thought if the prostate's gone, how can I get it again? And why are you checking my PSA? Or why would you check my PSA after surgery?

And then we do really try to address what I think is a common misunderstanding that Once the prostate is out, the patient is guaranteed to never recur. And patients, I think, are often surprised. What do you mean? I thought if the prostate's gone, how can I get it again? And why are you checking my PSA? Or why would you check my PSA after surgery?

And so it's much easier to address that beforehand than after the fact. Of course, not every single thing that we talk about at that initial visit is retained. That's impossible. But floating that is really helpful. I think I'd at least get to that point for every patient. Do I talk about, okay, now what happens if we hit that fork in the road?

And so it's much easier to address that beforehand than after the fact. Of course, not every single thing that we talk about at that initial visit is retained. That's impossible. But floating that is really helpful. I think I'd at least get to that point for every patient. Do I talk about, okay, now what happens if we hit that fork in the road?

And so it's much easier to address that beforehand than after the fact. Of course, not every single thing that we talk about at that initial visit is retained. That's impossible. But floating that is really helpful. I think I'd at least get to that point for every patient. Do I talk about, okay, now what happens if we hit that fork in the road?

I think I really make sure I address that with the higher risk patients, right? Patients with higher risk disease, where really that initial discussion is about

I think I really make sure I address that with the higher risk patients, right? Patients with higher risk disease, where really that initial discussion is about

I think I really make sure I address that with the higher risk patients, right? Patients with higher risk disease, where really that initial discussion is about

You know, we have option A, which is surgery with a distinct possibility, oftentimes greater than 50% possibility of undergoing additional treatment, likely to include radiation plus hormone therapy, or option B, which is radiation hormone therapy from the get-go.

You know, we have option A, which is surgery with a distinct possibility, oftentimes greater than 50% possibility of undergoing additional treatment, likely to include radiation plus hormone therapy, or option B, which is radiation hormone therapy from the get-go.

You know, we have option A, which is surgery with a distinct possibility, oftentimes greater than 50% possibility of undergoing additional treatment, likely to include radiation plus hormone therapy, or option B, which is radiation hormone therapy from the get-go.

And we talk about the pros and cons of each approach, but really ensuring that patients do understand that surgery is not a guaranteed one and done is important.

And we talk about the pros and cons of each approach, but really ensuring that patients do understand that surgery is not a guaranteed one and done is important.

And we talk about the pros and cons of each approach, but really ensuring that patients do understand that surgery is not a guaranteed one and done is important.

Yeah, like never. And so patients, I'm sure you have this experience too, or say, well, so then will I be cured or am I cured? And I just, I always say, and I say, you know, cure is a term that we just like all of us oncologists just really have a hard time saying, because pretty much everybody with a history of cancer has, of any kind of cancer, has some risk of that cancer coming back.